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Objectives: There is still no agreement about the best method of dealing with
malfunction of the aortic valve caused by aneurysm or dissection of the
aortic root. The experience, rationale, and development of a valve-preserv-
ing technique introduced and used since 1979 is described. Methods: During
this period 158 patients (78% of all patients undergoing resection of
aneurysm of the ascending aorta) were operated on using this technique.
Their ages ranged from 2 to 72 years (mean 46.6 years). Of the patients 107
were male and 51 were female. A total of 68 patients had skeletal
manifestations of Marfan’s syndrome. The original disease was chronic
aneurysm of the ascending aorta or root in 92 (58.2%), chronic dissection
in 17 (10.8%), and acute dissection in 49 (31%) patients. One hundred
eleven additional procedures were performed in 84 patients. In all there
were five early deaths (4.6% 6 2%) in the 109 patients with chronic
aneurysm and one death in the 103 patients operated on electively (0.97%
6 0.9%). Actuarial survival for patients operated on for chronic aneurysm
was 93.3%, 88.0%, 79.0%, and 57.9% at 1, 5, 10, and 15 years and 96.8%,
91.2%, 82.0%, and 60.0% for those operated on electively. Actuarial survival
for patients operated on for acute dissection was 72.8%, 63.4%, and 53.3%
at 1, 5, and 10 years. The probability of needing reoperation was 3.0% 6 2%,
11% 6 0.5%, and 11% 6 0.5% at 1, 5, and 10 years. There were no instances
of infective endocarditis or thromboembolic complications except in two
patients operated on early in the series who had cusp extension. No antico-
agulants were used. Echocardiography showed reduction in left ventricular
end-systolic and end-diastolic dimensions, which was maintained. At the end of
follow-up trivial or no aortic regurgitation was demonstrated in 63.6%, mild to
moderate in 33.3%, and severe in 3%. Conclusions: Valve-sparing operations are
possible in a large proportion of patients with aneurysms of the ascending
aorta and the medium and long-term results are encouraging. (J Thorac
Cardiovasc Surg 1998;115:1080-90)
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Aneurysm or dissection of the ascending aortainvolving the aortic root results in varying de-
grees of anatomic and functional abnormalities of
the aortic valve mechanism that need to be ad-
dressed at the time of operation. There is still no
agreement about the best method of achieving this,
with most of the patients undergoing composite
replacement of the aortic root and valve with a
mechanical valve.1-5 We believe that the “ideal”
operation for these patients is a valve-sparing pro-
cedure.6-8 We believe this because the aortic valve is
an extremely sophisticated, dynamic structure best
suited for its hemodynamic performance to main-
tain optimal left ventricular function, coronary flow,
and cardiac output under widely different physio-
logic and pathologic conditions while minimizing
mechanical stress on the valve cusps and because all
currently available valve substitutes have a signifi-
cant incidence of valve-related complications in
addition to the imperfect hemodynamic perfor-
mance. If they are to gain wide acceptance, valve-
conserving operations, however, need to be accu-
rately defined and shown to be safe, effective, and
durable. The early results of several small series of
valve-conserving operations have been encourag-
ing.9-12 We have developed a valve-conserving oper-
ation on the basis of the functional anatomy of the
aortic valve and the pathophysiology of aortic regur-
gitation in patients with aneurysm of the aortic
valve.6-8, 13, 14 This technique has been regularly
used since 1979. The purpose of this article is to
analyze our experience with this technique and
describe the rationale, development, and certain
technical aspects of the operation.
Rationale and development of the technique
Development of the technique was stimulated by
the knowledge that, at least initially, aortic regurgi-
tation in these patients is mainly or entirely caused
by aortic wall disease with sparing of the other
components of the valve mechanism. The compo-
nents of the aortic valve include the sinuses of
Valsalva, the sinotubular junction, the anulus, and
cusps (Fig. 1). These components are closely inte-
grated and tend to change their shape, size, and
relation to each other during the different phases of
Fig. 1. A and B, Sections of a normal aortic root.
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the cardiac cycle. This interaction is essential for the
smooth efficient functioning of the valve that results
in the cusp movements frequently preceding move-
ment of the blood inside the lumen, which have
important implications for the heart and the valve.
Preservation or recreation of the conditions that
allow this interaction is important for the short- and
long-term success of the valve-preserving operation.
One of these conditions is the capacity of the aortic
root to expand during systole, thus altering the
opening and closing characteristics of the cusps.15-17
This can be ensured by refashioning the Dacron
tube to produce three separate tongue-shaped pro-
cesses that act as individual sinuses (Fig. 2). Other
anatomic features relevant to this operation include
the fact that the aortic anulus is a definite anatomic
structure that is preserved in both acute dissection
and aneurysms13, 14 of the aorta and thus provides
excellent material for suturing the tongue-shaped
processes (sinuses) of the graft to the semilunar line
of attachment of the cusps to the aortic wall without
the use of pledgets or any foreign material. Finally,
the three components of the aortic cusp (the hinge,
body, and coapting surface) can be readily identified
at the time of operation by inspection while elevat-
ing the commissures. Providing adequate coapting
surfaces is an important objective of the operation.
In principle, therefore, the technique consists of
excision of all the diseased aortic wall with reconsti-
tution of the aortic valve mechanism while attempt-
ing to preserve its sophisticated functional charac-
teristics.
Surgical technique
This has been described elsewhere13, 14 and essentially
consists of establishing cardiopulmonary bypass with arte-
rial return to the aortic arch in a chronic aneurysm and the
femoral artery in acute dissection (the site of cannulation
in the aortic arch is later excised while performing an open
distal anastomosis with replacement of the aortic cannula
in the Dacron tube). The ascending aorta is clamped and
opened. Antegrade or retrograde (or both) cardioplegia is
used for myocardial protection. The aortic valve is in-
spected, and all the diseased aortic wall is excised to
within 1 mm of the aortic anulus (Fig. 2). The three
commissures are stretched in a vertical direction by the
use of three horizontal mattress sutures placed just above
the top of each commissure. The position of the aortic
cusps and their ability to coapt without prolapsing is tested
using a blunt instrument. The size of the Dacron tube is
determined by measuring the distance between the com-
missures, which produces maximal coaptation of the
cusps. The distance between the three commissures is
usually equal, and thus each represents one third of the
circumference. Because the circumference of a tube is
approximately three times the diameter, the measured
distance between the commissures in their new position
after excising the sinuses is a guide to the size of the tube
to be chosen. Alternatively, an obturator is used to
measure the “orifice” between the commissures after
excising the sinuses. In this series tubes varying from 24 to
34 mm diameter were used (Table I).
One end of the tube is trimmed to produce three
separate extensions designed to replace the three sinuses.
The width of each extension is measured to be equal to
one third of the circumference. The initial length of the
tongue-shaped process is made to equal at least one and a
half times the depth of the patients’ own aortic sinuses as
measured from the top of the commissures to the bottom
of the cusp. This allows for later trimming of the excess
Dacron after suturing the top of the commissures to the
bottom of the grooves. The reshaped Dacron extension is
then fixed to the aortic anulus at the line of attachment of
the cusps with continuous 4-0 monofilament sutures. The
coronary ostia are then mobilized and anastomosed to the
Dacron tube in the middle of the newly fashioned (Da-
cron) aortic sinus. This can be achieved without undue
Fig. 2. Operative technique of the valve-sparing opera-
tion used in this series (see text).
Table I. Size of Dacron tube used
Graft size 24 26 28 30 34
No. of patients 2 19 2 130 5
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tension in all patients, including those with very large
aneurysms. Occasionally in patients with acute dissection,
the proximal part of either coronary artery may be in-
volved in the disease process. This can be dealt with by
excision of the involved segment with direct anastomosis
of the coronary arterial wall to the Dacron tube or
exceptionally by interposition of an autologous saphenous
vein graft segment.
Patients and methods
Between September 1979 and April 1997, 158 patients
with aneurysms of the ascending aorta underwent valve-
sparing operations performed by one surgeon. This rep-
resents 78% of patients with aneurysms or dissection of
the ascending aorta involving the aortic root. All patients
were considered for a valve-sparing operation regardless
of the size of the aneurysm or anulus. Patients with severe
retraction or calcification of the aortic valve cusps were
considered unsuitable for repair. The presence of a bicus-
pid valve in the absence of cusp retraction was not
considered a contraindication for repair. Patient ages
ranged from 2 to 72 years (mean 46.6 years). There were
107 male and 51 female patients. The original disease was
chronic aneurysm of the ascending aorta or root in 92
(58.2%), chronic dissection in 17 (10.8%), and acute
dissection in 49 (31%). Sixty-eight patients had skeletal
manifestations of Marfan’s syndrome. New York Heart
Association (NYHA) status was class I in 14 (8.9%), class
II in 32 (20.3%), class III in 71 (44.9%), and class IV in 41
(25.9%). The preoperative degree of aortic regurgitation
was evaluated by a set of clinical and echocardiographic
criteria18, 19 and judged to be trivial in 15 (9.5%), mild in
37 (23.4%), moderate in 78 (49.4%), and severe in 28
(17.7%). Cardiothoracic ratio on the preoperative chest
x-ray film was less than 0.55 in 101 and more than 0.55 in
56. Pulmonary edema was present in 26. An echocardio-
gram was performed in all patients.
Coronary angiography was performed in those older
than 40 years of age. The operation was performed as an
emergency for acute dissection in 49 (31%) and for severe
low cardiac output syndrome in 26 (16.4%). One hundred
eleven additional procedures were performed in 84 pa-
tients (53.2%) (Table II). One hundred thirty (82%)
patients were followed up regularly at our hospital, when
a clinical examination, electrocardiogram, chest radio-
graph, and two-dimensional echocardiogram were per-
formed. Twenty-four patients lived abroad; up-to-date
information was obtained from their referring physician.
Seven patients (4.43%) were lost to follow-up.
Statistical analysis. Comparison of data between two
groups was performed with an unpaired t test. Compari-
son of data over time was done with a one-way analysis of
variance. The Kaplan-Meier product limit was used in the
estimation of long-term survival. The influence of differ-
ent potential risk factors on early, late, and overall
mortality was evaluated using multivariant analysis with
Cox’s proportional hazards. Parametric analysis (Weibull,
exponential, and logistic analysis) was used for identifica-
tion of risk factors. Logistic regression was used for
identification of risk factors for early mortality.
Results
Mortality. The 30-day (early) mortality for pa-
tients operated on for chronic aneurysms during the
whole period was 4.6% 6 2%. The causes of death
are shown in Table III. Four of the five patients who
died early were operated on as an emergency for low
cardiac output syndrome. The early mortality for
elective resection of chronic aneurysm was 0.97% 6
0.9% and 0% for those with Marfan’s syndrome.
Multiple regression analysis (Appendix 1) identified
duration of symptoms, NYHA class, history of myo-
cardial infarction, emergency operation, cardiopul-
monary bypass time, and crossclamp time as incre-
mental risk factors for early death in this group.
The early mortality for patients operated on for
acute dissection during the whole period was
18.37% 6 5% (nine patients, of whom four died of
a low cardiac output). Multivariate analysis revealed
that age was a significant incremental risk factor for
early death.
During a period of follow-up varying from 30 to
6396 days, mean 2025 (median 1541), there were 12
late deaths in the chronic aneurysm group with an
actuarial survival of 93.3%, 88.0%, 79.0%, and
57.9% at 1, 5, 10, and 15 years (Fig. 3) for the whole
group and 96.8%, 91.2%, 82.0%, and 60.0% for
those operated on electively (Fig. 3). The causes of
late deaths are shown in Table IV.
Multivariate analysis of patient or operation-re-
lated possible predictors of late death (Appendix 2)




Aortic arch replacement with head vessels
reimplanted
35
Proximal arch replacement 33
Coronary artery bypass grafts 23
Augmentation of aortic cusps 13
Mitral valve repair 2
Reimplantation of vein grafts 2
Coronary ostioplasty 2
Atrial septal defect closure 1
Total 111
Table III. Causes of early deaths in patients
operated on for chronic aneurysms (N 5 109)
Cause of death No. of patients
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after operation for all aneurysms identified the
presence of preoperative heart failure as a signifi-
cant risk factor. Univariate analysis found age, his-
tory of hypertension, and operation before 1987 also
to be significant risk factors.
The late survival for patients operated on for
acute dissection was significantly lower than that for
those operated on for chronic aneurysm (Fig. 4)
with the 1-, 5-, and 10-year actuarial survival being
72.8%, 63.4%, and 53.3% for those with acute
dissection. Overall survival for those with Marfan’s
syndrome was 90.9%, 85.3%, and 81.9% at 1, 5, and
10 years, better (p , 0.05) than 86.7%, 76.7%, and
60.7% for those without Marfan’s syndrome.
Postoperative aortic valve function. Postopera-
tive M-mode echocardiographic examination of the
aortic root showed “normal” box-shaped configura-
tion of the aortic cusps within the Dacron tube (Fig. 5),
with rapid opening to a full-sized orifice, gentle slow
early systolic closure, followed by rapid late closure. At
no time did the cusps touch the Dacron tube (Fig. 5).
The latter appeared to have a degree of “distensibility”
in the region of the aortic root with approximately a
10% increase in systolic diameter when compared with
the minimum diastolic dimension.
The presence and degree of aortic regurgitation
in the survivors was assessed by echocardiographic
criteria18 in a total of 55, 39, 20, and 5 patients at 1,
5, 10, and 15 years, respectively, and at latest
follow-up. At the end of follow-up it was judged to
be absent or trivial in 63.6%, mild to moderate in
33.3%, and severe in 3.0%. Aortic valve function
tended to be stable with progression occurring only
in the patients who had more than mild residual
regurgitation immediately after operation (Fig. 6).
The first patient with a large aneurysm of the
ascending aorta operated on in 1979 has normal
aortic function (as assessed clinically and by echo-
cardiography) 18 years after the operation and has
recently retired from her job as a physician. Further-
more, after a major car accident 2 years after
operation, she underwent aortic angiography, which
showed “normal” aortic root, coronary ostia, and
valve function.
Reoperation. During a follow-up period of 30 to
6396 days, mean 2025, 17 patients underwent reop-
eration on the aortic valve mainly for residual or
recurrent regurgitation (and 2 others were sched-
uled for reoperation making a total of 19 [12%]).
The cumulative probability of undergoing or await-
Fig. 3. Actuarial survival of all patients with chronic aneurysm (dotted line) and for those operated on
electively (solid line).
Table IV. Causes of late deaths in the chronic
aneurysm group (N 5 109)
Cause of death No. of patients
Myocardial infarction 2
Dissection of the descending aorta 2
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ing reoperation was 3.0% 6 2%, 11% 6 0.5%, and
11% 6 0.5% at 1, 5, and 10 years. The freedom from
reoperation is shown in Fig. 7. There were no
operative deaths in this group, but three patients
died later. Reoperation was more common in pa-
tients with a longer duration of symptoms preoper-
atively. Freedom from reoperation in the Marfan’s
syndrome group was 93.8%, 88.5%, and 86% at 1, 5,
and 10 years, which was similar to the 98.8%, 89%,
and 89% in the non-Marfan’s syndrome group.
Valve-related complications. Routine anticoagu-
lation was not used in this series; no thromboem-
Fig. 4. Actuarial survival of patients after a valve-sparing procedure for acute dissection.
Fig. 5. Postoperative M-mode echocardiogram showing excellent opening of the aortic cusps, which do
not touch the Dacron tube. The cusps close gradually during systole then with a moderate closure time
during diastole. Arrowheads denote valve open. RVOT, Right ventricular outflow tract; Ao, aorta; LA, left
atrium.
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bolic complications or endocarditis were encoun-
tered except in two patients operated on early in the
series who had additional cusp extension using calf
pericardium. One of them had endocarditis develop
5 years postoperatively and was successfully treated
by valve replacement, and the other had one episode
of thromboembolism develop.
Symptomatic status. After operation an im-
provement in symptomatic status observed early, as
assessed by NYHA class, was maintained in most
patients, with 97.4% of those followed up for 10
years (n 5 24) being in class I or II.
Cardiothoracic ratio. Postoperatively diminution
in heart size as indicated by a reduction of the
cardiothoracic ratio observed early tended to be
maintained except in the patients who had aortic
regurgitation develop.
Discussion
This study presents the rationale of a valve-
preserving operation for patients with aortic aneu-
rysm, dissection, or both, developed in the late
seventies; it also serves to characterize the pattern of
survival, aortic valve function, and valve-related
complications over a period of up to 19 years. In
addition, it has identified several incremental risk
factors for either death or reoperation that could
help to improve patient selection and timing of
operation.
The concept of valve repair is extremely appealing
and is now well established and widely practiced for
the mitral and tricuspid valves. In contrast, aortic
valve repair has tended to lag behind.20-23 This could
be due to the smaller size of the aortic outflow, its
cylindric structure, and the presence of subtle inter-
action between components of the aortic valve
mechanism. These factors make it difficult to render
the aortic valve competent without plication, partial
excision, or extension of the flimsy valve cusps. In
addition, the materials used for cusp extension are
thrombogenic and subject to degeneration and en-
docarditis, which defeats the purpose of the opera-
tion. These problems do not apply to patients with
aortic aneurysm or dissection of the aortic root in
which the disease process is largely or completely
localized to the aortic wall. Although the term
“annuloaortic ectasia,” commonly used to describe
the disease in these patients, implies gross dilatation
of the anulus, in our experience the dilatation affects
the sinuses and the sinotubular junction with sparing
of the anulus. The latter is also completely spared in
acute dissection. In addition, these patients have
aortic valve cusps capable of functioning normally
for long periods of time despite the presence of
histologic abnormalities, particularly in patients with
Marfan’s syndrome. The technique used in this
series aims at excising all the diseased aortic wall
with reconstitution of the valve mechanism in a
fashion to allow normal interaction between differ-
ent components of the valve. This is achieved by
preserving independent mobility of the aortic si-
nuses without “crowding” of the aortic cusps within
the Dacron tube. This should prevent late degener-
ation of the cusps such as that described by Gallo
and colleagues,24 which was ascribed by the authors
to “replacement of the normal dynamic aortic root
with a noncompliant conduit which must affect the
function of the aortic valve complex.” Postoperative
M-mode echocardiograms in our patients showed
excellent mobility of the cusps, which opened fully
without touching the Dacron sinuses at any stage
with apparently normal opening and closing charac-
teristics. In addition, preserved distensibility of the
aortic root was observed after operation. These
findings could explain the stable function in our
series (Fig. 6) and the relatively low rate of reop-
eration over the follow-up period (Fig. 7). Reopera-
tion was more common in patients with a longer
duration of symptoms preoperatively; this strongly
Fig. 6. Presence or absence of aortic regurgitation and its
degree postoperatively.
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suggests that early operation before the onset of
secondary changes in the cusps may reduce or
eliminate the incidence of this complication. Fur-
thermore, all the patients who required reoperation
had at least mild to moderate aortic regurgitation
shortly after operation, suggesting imperfect repair
that could have been contributed to by secondary
changes in the cusps caused by long-standing regur-
gitation. Valve competence can usually be achieved
by resuspension of the aortic valve, particularly in
patients operated on before shrinkage and further
prolapse of the cusps produced by the turbulence of
aortic regurgitation. In these patients several ma-
neuvers aimed at producing sufficient coaption of
the cusps can be used. These include controlled
approximation of the right, noncoronary, and left
coronary sinuses with a 4 mm band of Dacron graft
material placed on the outside and fixed to the
bottom of each sinus, plication of the thickened
central border of the prolapsing cusps, or both.
Insertion of a band was used in six patients in this
series. Cusp extension is not recommended for the
reasons mentioned earlier. We believe that postop-
erative bleeding can be minimized by ensuring wide
excision of the diseased aortic sinuses with place-
ment of the sutures in the firm aortic anulus along
the line of attachment of the cusps coupled with
ensuring that the slightly rigid Dacron tube coapts to
the patient’s tissues. This obviates the need for the
use of either fibrin sealants or adhesive glue (resor-
cinol), which we believe to be unnecessary.
The operation used in this series is safe as indi-
cated by the fact that the early mortality for patients
operated on electively in the entire series was
0.97%, with no mortality in those with the clinical
manifestation of Marfan’s syndrome. Multivariate
analysis showed duration of symptoms, NYHA func-
tional class, history of myocardial infarction, and
Fig. 7. Freedom from reoperation (solid line) and 95% confidence limits (dotted line). No patients died
while awaiting operation.
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emergency operation as incremental risk factors for
early death.
In this series late survival depended on the orig-
inal type of disease with an actuarial survival of
patients undergoing resection of chronic aneurysm
of 93.3%, 88.0%, 79.0, and 57.9% at 1, 5, 10, and 15
years and 96.8%, 91.2%, 82.0%, and 60% in those
undergoing an elective procedure. These figures
compare favorably to those reported for composite
replacement of the aortic root using prosthetic
valves.1-5 In the absence of a randomized prospec-
tive trial or accurately matching patient characteris-
tics any meaningful comparison is difficult, if not
impossible. However, the valve-sparing operation
should yield superior results in terms of late survival
because of superior hemodynamics, virtual lack of
valve-related complications, and the apparently sta-
ble aortic valve function. The pattern of early and
late survival after repair can be expected to improve
further because of increased experience and earlier
operations; this is suggested by the multivariant
analysis of predictors of survival in this series.
In this series routine anticoagulation was not
used. Endocarditis and thromboembolism were not
encountered except in two patients operated on
early in the series in whom cusp extension using
glutaraldehyde-tanned pericardium was used. The
low incidence of valve-related complications and the
lack of need for anticoagulation could have impor-
tant implications on the quality of life in these
patients.
Patients with the Marfan’s syndrome are an im-
portant group that can benefit greatly from this
operation. This applies to those who have acute
dissections, chronic aneurysms, or both. This stems
from the fact that these patients are usually younger
and have a potentially compromised left ventricle,
and the lack of anticoagulation and better hemody-
namics can be particularly valuable. In addition,
they could require orthopedic interventions that
could be rendered hazardous by anticoagulation
necessitated by the use of a prosthetic valve. In this
series clinical manifestations of Marfan’s syndrome
were present in 68 patients. For these patients
actuarial survival was 90.9%, 85.3%, 81.9%, and
63.8% at 1, 5, 10, and 15 years.
In conclusion, this study has shown that the
valve-sparing operation designed to maintain mobil-
ity of the different valve components can be per-
formed in most patients with chronic aneurysms or
dissection of the aortic root. The early and long-
term results are very encouraging, particularly in
patients operated on early in the natural history of
the disease. These findings warrant wider applica-
tion of the technique.
We thank the Department of Mathematics and Statis-
tics at Imperial College for performing the statistical
analysis.
R E F E R E N C E S
1. Bentall HH, De Bono A. A technique for complete replace-
ment of the ascending aorta. Thorax 1968;23:338-9.
2. Crawford ES, Kirklin JW, Naftel DC, Svensson LG, Coselli
JS, Safi HJ. Surgery for acute dissection of ascending aorta.
J Thorac Cardiovasc Surg 1992;104:46-59.
3. Kouchoukas NT, Wareing TH, Murphy SF, Perillo JB.
Sixteen-year experience with aortic root replacement: results
of 172 operations. Ann Surg 1991;214:308-20.
4. Gott VL, Laschinger JC, Cameron DE, Dietz HC, Greene
PS, Gillinov AM, et al. The Marfan syndrome and the
cardiovascular surgeon. 1996;10:149-58.
5. Cabrol C, Pavie A, Mesnildrey, et al. Long term results with
total replacement of the ascending aorta with reimplantation
of the coronary arteries. J Thorac Cardiovasc Surg 1986;91:
17-25.
6. Fagan A, Yacoub MH, Pillai R, Radley-Smith R. Dacron
replacement of the ascending aorta and sinuses with re-
suspension of the aortic valve and re-implantation of the
coronary arteries: a new method for treatment of aneurysmal
or acute dissection of the aortic root. Proceedings of Joint
International Cardiovascular and Thoracic Surgical Confer-
ence, Stockholm. Scand J Cardiothoracic Surg. 1982.
7. Fagan A, Pillai R, Radley-Smith R, Yacoub MH. Results of
new valve conserving operation for treatment of aneurysms
or acute dissection of aortic root. Br Heart J 1983;49:302.
8. Yacoub MH, Fagan A, Stassano P, Radley-Smith R. Results
of valve conserving operations for aortic regurgitation. Cir-
culation 1983;68:311-21.
9. David TE, Feindel M. An aortic valve-sparing operation for
patients with aortic incompetence and aneurysm of the
ascending aorta. J Thorac Cardiovasc Surg 1992;103:617-22.
10. Simon P, Mortiz A, Moidl R, Kupilik N, Grabenwoeger M,
Erlich M, et al. Aortic valve resuspension in ascending aortic
aneurysm repair with aortic insufficiency. Ann Thorac Surg
1995;60:176-80.
11. Schafers HJ, Borst HG. Valve sparing operation in aortic
root ectasia. In: Cox JL, Sundt TM, editors. Operative
techniques in cardiac and thoracic surgery: a comparative
atlas. Philadelphia: WB Saunders; 1996. p. 38-43.
12. Heinemann MK, Buehner B, Jurmann, Laas J, Borst HG.
Aortic disease in Marfan syndrome: surgery, results and
special aspects. In: Hetzer R, Gehle P, Enneker J, editors.
Cardiovascular aspects of Marfan syndrome. Darmstadt:
Steinkopff; 1995. p. 101-7.
13. Yacoub MH, Sundt TM, Rasmi N. Management of aortic
valve incompetence in patients with Marfan syndrome. In:
Hetzer R, Gehle P, Ennker J, editors. Cardiovascular aspects
of Marfan syndrome. Darmstadt: Steinkopff; 1995. p. 71-81.
14. Yacoub MH. Valve-conserving operation for aortic root
aneurysm or dissection. In: Cox JL, Sundt TM, editors.
Operative techniques in cardiac and thoracic surgery: a
The Journal of Thoracic and
Cardiovascular Surgery
May 1998
1 0 8 8 Yacoub et al.
comparative atlas. Philadelphia: WB Saunders; 1996. p. 57-
67.
15. Brewer RJ, Capati B, Nolan SP. Aortic root dynamics: the
major determinant of normal valvular function. Circulation
1973;9:48-53.
16. Zimmerman J. The functional and surgical anatomy of the
aortic valve. Isr J Med Sci 1969;5:862-6.
17. Brewer RJ, Deck D, Capati B, Nolan SP. The dynamic aortic
root: its role in aortic valve function. J Thorac Cardiovasc
Surg 1975;72:413-8.
18. Perry GJ, Helmcke F, Nanda NC, Byard C, Soto B. Evalua-
tion of aortic insufficiency by colour flow mapping. J Am Coll
Cardiol 1987;9:952-9.
19. Yacoub MH, Rasmi NRH, Sundt TM, et al. Fourteen-year
experience with homovital homografts for aortic valve re-
placement. J Thorac Cardiovasc Surg 1995;110:186-94.
20. Yacoub MH, Khan H, Stavri G, Shinebourne E, Radley-
Smith R. Anatomic correction of the syndrome of prolapsing
right coronary aortic cusp, dilatation of the sinus of Valsava,
and ventricular septal defect. J Thorac Cardiovasc Surg
1997;113:253-61.
21. Cosgrove DM, Fraser CD. Aortic valve repair. In: Cox JL,
Sundt TM, editors. Operative techniques in cardiac and
thoracic surgery: a comparative atlas. Philadelphia: WB
Saunders; 1996. p. 30-7.
22. Duran C. Aortic valve repair and reconstruction. In: Cox JL,
Sundt TM, editors. Operative techniques in cardiac and
thoracic surgery: a comparative atlas. Philadelphia: WB
Saunders; 1996. p. 15-29.
23. Yacoub MH, Khaghani A, Dhalla N. Aortic valve replace-
ment using unstented dura or calf pericardium: early and
medium results. In: Bodnar E, Yacoub M, editors. Biological
and bioprosthetic valves. New York: York Medical Books;
1986. p. 684-90.
24. Gallo R, Jumar N, Al Halees Z, Duran C. Early failure of
aortic valve conservation in aortic root aneurysm. J Thorac
Cardiovasc Surg 1995;109:1011-2.
Discussion
Dr. Tirone E. David (Toronto, Ontario, Canada). Our
experience with the aortic valve–sparing operations in
patients with aortic aneurysms is more recent than yours.
We only started doing them in 1988, and to date, we have
operated on 105 patients.
During the same interval, we had done 111 composite
replacements of the aortic valve and the ascending aorta.
Therefore approximately half of our patients with aortic
root aneurysms had this operation. The other ones who
could not have it mostly had the bicuspid aortic valve, and
that is the reason why we did not perform them.
Unlike what you described, we perform multiple differ-
ent operations in these patients. Only about half of them
had all three aortic sinuses replaced. The decision to
replace the aortic sinuses was dependent on the patho-
logic condition and the mechanism of aortic insufficiency.
Many patients who have an ascending aortic aneurysm
do not have a dilated aortic anulus or sinus of Valsalva,
and aortic insufficiency is solely due to distortion of the
sinotubular junction. By adjusting the sinotubular junction
alone, we have been able to make these aortic valves
competent.
I was surprised to hear you say that patients with
Marfan’s syndrome do not have annuloaortic ectasia and
that this was a misnomer. Our patients with Marfan’s
syndrome and other patients as well, who had a dilated
aortic root, almost consistently had a large aortic anulus.
The dilatation is only in the fibrous component of the
outflow tract, and I believe that in those patients, one has
to perform a reduction annuloplasty to allow the leaflets
to coapt better.
I have a few questions for Sir Magdi. The first one is, do
you not believe that annuloplasty is necessary in patients
with dilated aortic anulus?
Second, would you tell us which patients had their
procedure fail? Of the 19 failures occurring in 158 pa-
tients, were they all Marfan’s syndrome? How many had
Marfan’s syndrome? We have the impression, although
our data do not support this yet, that they are more likely
to fail. We have had only one failure; however, we have
operated only on 28 patients with Marfan’s syndrome.
Finally, how do you handle the patients who have a
fairly good bicuspid aortic valve and an ascending aortic
aneurysm?
Dr. Gerhard Ziemer (Tuebingen, Germany). Following
your suggestion almost 10 years ago, I performed the same
operation in appropriate patients; however, I was some-
what more choosy. I have two questions specifically re-
garding the management of patients with bicuspid aortic
valves.
The first is, in acute aortic dissection and bicuspid aortic
valves at any age, in Hannover before and at my institu-
tion now, we do not reconstruct the aortic root but
perform a Bentall procedure. So my question is, do you
differentiate your approach in aortic dissection according
to whether there is a bicuspid or tricuspid aortic valve?
Second, your youngest patient was 2 years of age. I
assume it was a child with Marfan’s syndrome, as was my
youngest patient at 31⁄2 years of age. There are more
between 10 and 13 years of age. In these young patients
with nondissecting Marfan’s syndrome ascending aortic
aneurysms, I preserve the aortic valve even if it is a
bicuspid valve. Feeling somewhat insecure about the
long-term function in these patients, however, I use a
polytetrafluoroethylene* graft instead of a Dacron graft,
possibly facilitating reoperation.
My question is, what is your approach to these patients
and is your approach different related to age and whether
or not Marfan’s syndrome is present? Is there a functional
follow-up difference in bicuspid valves?
Dr. Max B. Mitchell (Denver, Colo.). I was going to ask
the same question regarding whether you would apply this
operation to the patient with a bicuspid aortic valve.
Mr. Yacoub. Thank you. Dr. David, you asked several
very relevant questions. The first has to do with whether
we replace all sinuses routinely. Like you, we only rou-
tinely replace the three sinuses in patients with Marfan’s
syndrome because we know that the sinus tissue is abnor-
mal; in the past, sparing any of the sinuses resulted in
recurrence of the aneurysm. However, in patients with
acute dissection, chronic aneurysm, or both, who do not
have Marfan’s syndrome, we would only replace the
*Gore-Tex vascular graft, registered trademark of W. L. Gore &
Associates, Inc., Newark, Del.
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sinuses that are involved in the disease, be it dissection or
dilatation.
The next point is about annuloaortic ectasia. I wanted
to be slightly controversial to make the point. I agree,
there is some dilatation that is not progressive. However,
to put all the blame on the anulus, we believe, is wrong
because the amount of cusp tissue in patients with
Marfan’s syndrome and other patients with aneurysms of
the ascending aorta and root is sufficient for the size of the
anulus. The anulus is spared in Marfan’s syndrome largely
because fibrillin seems to affect more elastic tissue than
fibrous tissue.
The point we make is that in most patients with
Marfan’s syndrome and aneurysms, the problem is in the
sinuses and the sinotubular junction. If we operate early
enough, there will be no need to reduce the size of the
anulus. We only reduce the size of the anulus if the cusp
tissue has shrunken and retracted, and that is the point
when we would try to reduce the size by approximating the
bottom of the three sinuses after performing the opera-
tion to make sure that there is still mobility in the cusps.
As to your next point, the recurrence rate or the
reoperation rate was not greater in the Marfan’s syn-
drome patients. Only six patients were, and if one calcu-
lates the cumulative probability of reoperation, it was not
higher in patients with Marfan’s syndrome. We were quite
pleased about that.
The final point I believe was about bicuspid aortic
valves. In this series we have preserved valves in two
patients, I believe, with bicuspid aortic valves. We believe
that the presence of a bicuspid valve, per se, if the cusps
are not diseased, is not a contraindication to the use of
this operation, and that applies to Dr. Ziemer’s and Dr.
Mitchell’s questions. Indeed, in the younger patients, we
would preserve the valve, be it bicuspid or not. A similar
situation exists in the arterial switch operation. We have
had five or six patients who had bicuspid pulmonary valves
(future aortic valves), and that did not stop us from
performing the operation. Some of these patients have
been followed up for nearly 10 years with no evidence of
aortic valve malfunction, which supports the notion that
the presence of a bicuspid valve is not necessarily a
contraindication to the use of a valve-conserving opera-
tion.
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